Journal
CANCER SCIENCE
Volume 113, Issue 1, Pages 7-16Publisher
WILEY
DOI: 10.1111/cas.15194
Keywords
colorimetric aptasensor; electrochemical aptasensor; fluorescent aptasensor; tumor diagnosis; tumor marker
Categories
Funding
- State Project for Essential Drug Research and Development [2019ZX09301132]
- NUS School of Medicine Kickstart Initiative [NUHSRO/2021/044/Kickstart/09/LOA]
- Guangxi Key Research and Development Project [AB20117001]
- Scientific and Technological Innovation Major Base of Guangxi [2018-15-Z04]
- NUS School of Medicine Nanomedicine Translational Research Programme [NUHSRO/2021/034/TRP/09/Nanomedicine]
- National University of Singapore Start-up Grant [NUHSRO/2020/133/Startup/08]
Ask authors/readers for more resources
Aptamers, short oligonucleotide chains with high specificity, low cost, and good biocompatibility, have been widely used as targeting elements of biosensors in non-invasive tumor imaging and treatment. This review summarizes recent advances in using aptamer-based biosensors for tumor diagnosis, covering different analytical methods such as electrochemistry analysis, colorimetry analysis, and fluorescence analysis. The potential advantages of aptamer-based biosensors in tumor theranostics and post-treatment monitoring are also discussed.
An aptamer is a short oligonucleotide chain that can specifically recognize targeting analytes. Due to its high specificity, low cost, and good biocompatibility, aptamers as the targeting elements of biosensors have been applied widely in non-invasive tumor imaging and treatment in situ to replace traditional methods. In this review, we will summarize recent advances in using aptamer-based biosensors in tumor diagnosis. After a brief introduction of the advantage of aptamers compared with enzyme sensors and immune sensors, the different sensing designs and mechanisms based on 3 signal transduction modes will be reviewed to cover different kinds of analytical methods, including: electrochemistry analysis, colorimetry analysis, and fluorescence analysis. Finally, the prospective advantages of aptamer-based biosensors in tumor theranostics and post-treatment monitoring are also evaluated in this review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available